Atreca, Inc. Banner Image

Atreca, Inc. has reached its limit for free report views

Work for Atreca, Inc.? Upgrade Your Profile and unlock all your annual reports.

Atreca, Inc.

  • Ticker BCEL
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Atreca, Inc. Logo Image
  • 51-200 Employees
  • Based in South San Francisco, California
Atreca is a biopharmaceutical company developing novel antibody-based immunotherapeutics generated by its differentiated discovery platform. Atreca’s platform allows access to an unexplored landscape in oncology through the identification of unique antibody-target pairs generated by the human immune system during an active immune response against tumors. These antibodies provide the basisMore for first-in-class therapeutic candidates, such as their lead product candidate ATRC-101. A Phase 1b study evaluating ATRC-101 in multiple solid tumor cancers is currently enrolling patients.
Atreca, Inc.

Most Recent Annual Report

Atreca, Inc. MOST RECENT 2020 Annual Report and Form 10K

Report Locked. Atreca, Inc. has reached its limit for free report views.

Older/Archived Annual Reports